PubRank

Erythropoietin priming improves the vasculogenic potential of G-CSF mobilized human peripheral blood mononuclear cells.

PubWeight™: 0.77‹?›

🔗 View Article (PMID 25082847)

Published in Cardiovasc Res on July 31, 2014

Authors

Jeehoon Kang1, Ji-Yeon Yun2, Jin Hur3, Jin-A Kang2, Jae-Il Choi2, Seung Bum Ko2, Jaewon Lee4, Ju-Young Kim4, In-Chang Hwang5, Young-Bae Park6, Hyo-Soo Kim7

Author Affiliations

1: Department of Internal Medicine and Cardiovascular Center, Seoul National University Hospital, 101 DaeHak-ro, JongRo-gu, Seoul 110-744, Korea National Research Laboratory for Stem Cell Niche, Seoul National University College of Medicine, Seoul, Korea Molecular Medicine and Biopharmaceutical Sciences, Seoul National University, Seoul, Korea.
2: National Research Laboratory for Stem Cell Niche, Seoul National University College of Medicine, Seoul, Korea Molecular Medicine and Biopharmaceutical Sciences, Seoul National University, Seoul, Korea.
3: Department of Internal Medicine and Cardiovascular Center, Seoul National University Hospital, 101 DaeHak-ro, JongRo-gu, Seoul 110-744, Korea National Research Laboratory for Stem Cell Niche, Seoul National University College of Medicine, Seoul, Korea Innovative Research Institute for Cell Therapy, Seoul National University Hospital, Seoul, Korea.
4: National Research Laboratory for Stem Cell Niche, Seoul National University College of Medicine, Seoul, Korea Innovative Research Institute for Cell Therapy, Seoul National University Hospital, Seoul, Korea.
5: Department of Internal Medicine and Cardiovascular Center, Seoul National University Hospital, 101 DaeHak-ro, JongRo-gu, Seoul 110-744, Korea Molecular Medicine and Biopharmaceutical Sciences, Seoul National University, Seoul, Korea.
6: Department of Internal Medicine and Cardiovascular Center, Seoul National University Hospital, 101 DaeHak-ro, JongRo-gu, Seoul 110-744, Korea Innovative Research Institute for Cell Therapy, Seoul National University Hospital, Seoul, Korea.
7: Department of Internal Medicine and Cardiovascular Center, Seoul National University Hospital, 101 DaeHak-ro, JongRo-gu, Seoul 110-744, Korea National Research Laboratory for Stem Cell Niche, Seoul National University College of Medicine, Seoul, Korea Molecular Medicine and Biopharmaceutical Sciences, Seoul National University, Seoul, Korea Innovative Research Institute for Cell Therapy, Seoul National University Hospital, Seoul, Korea hyosoo@snu.ac.kr.

Articles citing this ↘

Novel applications of trophic factors, Wnt and WISP for neuronal repair and regeneration in metabolic disease. Neural Regen Res (2015) 0.94

WISP1: Clinical insights for a proliferative and restorative member of the CCN family. Curr Neurovasc Res (2014) 0.88

Erythropoietin and diabetes mellitus. World J Diabetes (2015) 0.80

Regeneration in the nervous system with erythropoietin. Front Biosci (Landmark Ed) (2016) 0.76

Erythropoietin and mTOR: A "One-Two Punch" for Aging-Related Disorders Accompanied by Enhanced Life Expectancy. Curr Neurovasc Res (2016) 0.75

Strategy to Prime the Host and Cells to Augment Therapeutic Efficacy of Progenitor Cells for Patients with Myocardial Infarction. Front Cardiovasc Med (2016) 0.75